Search

everythinglearnresearchcommunity

for

Search:↓

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

People with hair loss are more likely to have anxiety.

Gender and social factors, not just biology, affect COVID-19 death rates.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

We need safe, affordable drugs to fight coronaviruses effectively.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Genetic differences affect how people respond to COVID-19.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Women are more likely to have long-term post-COVID symptoms than men.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Pomegranate has health benefits and new methods are improving its use in supplements.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.